Kathy Guo

3.1k total citations · 2 hit papers
12 papers, 2.3k citations indexed

About

Kathy Guo is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Kathy Guo has authored 12 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Kathy Guo's work include Liver Disease Diagnosis and Treatment (8 papers), Diet, Metabolism, and Disease (2 papers) and Hepatitis C virus research (2 papers). Kathy Guo is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Diet, Metabolism, and Disease (2 papers) and Hepatitis C virus research (2 papers). Kathy Guo collaborates with scholars based in United Kingdom, United States and China. Kathy Guo's co-authors include Darren Barton, Diana Hull, Matthew J. Armstrong, Jeremy Tomlinson, Philip N. Newsome, Stephen Gough, Jonathan Hazlehurst, Rachel M. Brown, Stefan G. Hübscher and Deborah Stocken and has published in prestigious journals such as The Lancet, Nature Cell Biology and Advanced Drug Delivery Reviews.

In The Last Decade

Kathy Guo

12 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

2015 1.6k citations Matthew J. Armstrong, Piers Gaunt et al. The Lancet profile →
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

2015 351 citations Matthew J. Armstrong, Diana Hull et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathy Guo United Kingdom	8	1.7k	1.3k	548	498	485	12	2.3k
Salvatore Sutti Italy	24	1.1k 0.7×	249 0.2×	404 0.7×	548 1.1×	193 0.4×	51	1.7k
Adrien Guillot Germany	20	919 0.6×	172 0.1×	491 0.9×	569 1.1×	259 0.5×	52	1.7k
Aritz Lopategi Spain	14	520 0.3×	129 0.1×	307 0.6×	352 0.7×	212 0.4×	17	1.4k
Narcissus Teoh Australia	12	529 0.3×	177 0.1×	361 0.7×	323 0.6×	280 0.6×	17	1.1k
Masaharu Yamazaki Japan	22	436 0.3×	165 0.1×	453 0.8×	469 0.9×	110 0.2×	57	1.3k
Morgane Baron France	9	484 0.3×	171 0.1×	422 0.8×	112 0.2×	159 0.3×	16	986
Zouher Majd France	15	301 0.2×	256 0.2×	864 1.6×	50 0.1×	354 0.7×	24	1.5k
Carlos M. Rodríguez‐Ortigosa Spain	18	264 0.2×	113 0.1×	382 0.7×	273 0.5×	234 0.5×	37	1.1k
Lulu Wang China	12	388 0.2×	186 0.1×	163 0.3×	111 0.2×	87 0.2×	28	655
Akihisa Miyazaki Japan	17	422 0.3×	59 0.0×	303 0.6×	478 1.0×	332 0.7×	47	1.2k

Countries citing papers authored by Kathy Guo

Since Specialization

Citations

This map shows the geographic impact of Kathy Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Guo more than expected).

Fields of papers citing papers by Kathy Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Guo. The network helps show where Kathy Guo may publish in the future.

Co-authorship network of co-authors of Kathy Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Guo. A scholar is included among the top collaborators of Kathy Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Guo. Kathy Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Li, Fuming, Peiwei Huangyang, Michelle Burrows, et al.. (2020). FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome. Nature Cell Biology. 22(6). 728–739. 151 indexed citations

Oo, Ye Htun, Lee Jenkins, Hannah C. Jeffery, et al.. (2019). Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis. JHEP Reports. 1(4). 286–296. 59 indexed citations

Guo, Kathy, et al.. (2019). The Modified Ultrasound-Guided Distal-to-Proximal Carpal Tunnel Injection With Median Nerve Hydrodissection: A Retrospective Safety Review of 827 Procedures. Hand. 16(3). 407–409. 5 indexed citations

Armstrong, Matthew J., Piers Gaunt, Guruprasad P. Aithal, et al.. (2015). Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. The Lancet. 387(10019). 679–690. 1554 indexed citations breakdown →

Armstrong, Matthew J., Diana Hull, Kathy Guo, et al.. (2015). Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis. Journal of Hepatology. 64(2). 399–408. 351 indexed citations breakdown →

Rowe, Ian, Damien C. Tully, Matthew J. Armstrong, et al.. (2015). Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation. Liver Transplantation. 22(3). 287–297. 26 indexed citations

Armstrong, Matthew J., Diana Hull, Kathy Guo, et al.. (2014). Effect of liraglutide on adipose insulin resistance and hepatic de-novo lipogenesis in non-alcoholic steatohepatitis: substudy of a phase 2, randomised placebo-controlled trial. The Lancet. 383. S21–S21. 7 indexed citations

Rowe, Ian, Matthew J. Armstrong, Richard Parker, et al.. (2014). Effect of scavenger receptor B-I antagonist, ITX5061, on early hepatitis C virus kinetics in liver transplantation: results of a phase 1b clinical trial. The Lancet. 383. S90–S90. 1 indexed citations

Armstrong, Matthew J., Darren Barton, Piers Gaunt, et al.. (2013). Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial. BMJ Open. 3(11). e003995–e003995. 39 indexed citations

10.

Guo, Kathy & Damir Janigro. (2013). New Immunological Approaches in Treating and Diagnosing CNS Diseases. Pharmaceutical Patent Analyst. 2(3). 361–371. 1 indexed citations

11.

Hull, Diana, et al.. (2012). Patient and public involvement to support liver disease research. British Journal of Nursing. 21(16). 972–976. 11 indexed citations

12.

Marchi, Nicola, Kathy Guo, Chaitali Ghosh, et al.. (2011). Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents. Advanced Drug Delivery Reviews. 64(7). 605–613. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact